Delivering drugs by erosion

Egalet A/S says its Egalet polymer "erosion" drug delivery technology offers advantages over similar diffusion-based drug delivery techniques. This week, the company was to announce a $27.6 million series B round that should give it the means to prove its point.

Egalet (Vaerlose, Denmark) plans to begin Phase III testing of its two most advanced products during the first quarter of 2007: continuous-release morphine for chronic pain and an undisclosed continuous-release product for cardiovascular disease. ...